Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. Fertin 1mg tablets Fertin 2 mg tablets Fertin 3mg tablets Fertin 4mg tablets {glimepiride}

PACKAGE LEAFLET: INFORMATION FOR THE USER. GLIMEPIRIDE WINTHROP 1 mg, 2 mg, 3 mg, 4 mg, and 6 mg tablets glimepiride

Package leaflet: Information for the user

TRICAL 1 mg, 2 mg and 3 mg tablets

Package leaflet: Information for the user. Prandin 0.5 mg tablets Prandin 1 mg tablets Prandin 2 mg tablets. Repaglinide

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. PROSCAR 5 mg Film-coated Tablets (finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

PACKAGE LEAFLET: Information for the user. METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride)

SIOFOR mg film-coated tablets

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets

DIPRIAN 80 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

PACKAGE LEAFLET: INFORMATION FOR THE USER

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: Information for the patient. Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets Saxagliptin

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

What is in this leaflet

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

Package leaflet: Information for the patient Minodiab 5 mg Tablets Glipizide

Package leaflet: Information for the user

Package leaflet: Information for the patient

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Irbenida H 150mg/12,5mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Pravat 40 mg tablets. Pravastatin sodium

XYZAL 5 MG FILM-COATED TABLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets

PACKAGE LEAFLET: INFORMATION FOR USER ROPINIROLE 2 mg FILM-COATED TABLETS. Ropinirole

Read all of this leaflet carefully before you start taking this medicine.

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

VI.2 Elements for a Public Summary

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

PATIENT INFORMATION LEAFLET. PACKAGE LEAFLET: INFORMATION FOR THE USER Artin 75 mg tablets Artin 150 mg tablets Artin 300 mg tablets.

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine)

PATIENT INFORMATION LEAFLET TEXAMER

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

LEAFLET: INFORMATION FOR THE USER. Freshalgin 500th mg tablets Metamizole sodium (M etamizol sodium)

WHOPAR part 3 Suppliers submission of the SRA approved text. Package Leaflet: Information for the user

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the user

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

Package leaflet: Information for the user. Fluvastatin

Motens 2 mg and 4 mg Tablets lacidipine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ondansetron BMM Pharma 8 mg film-coated tablets. Ondansetron

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

Package leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride

GLUCOPHAGE 500 mg mg mg

Onglyza CONSUMER MEDICINE INFORMATION

PACKAGE LEAFLET: INFORMATION FOR THE USER Oxybutynin Hydrochloride 3mg Tablets

GLORION HIKMA PHARMACEUTICALS

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

Dulcolax 5 mg, film-coated tablets

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

2 What you need to know before you take Naramig

PACKAGE LEAFLET: INFORMATION FOR THE USER

ALDOMET Film-coated Tablets 250 mg ALDOMET Film-coated Tablets 500 mg (Methyldopa)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Mylan 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Sibelium 5 mg Tablets flunarizine

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Cinfalair 10 mg film-coated tablets Montelukast

Package leaflet: Information for the patient Glipizide 5 mg Tablets (glipizide)

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. - If you have further questions, please ask your doctor or your pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Dialosa is and what it is used for 2. Before you take Dialosa 3. How to use Dialosa 4. Possible side effects 5. How to store Dialosa 6. Further information 1. WHAT DIALOSA IS AND WHAT IT IS USED FOR Dialosa lowers blood sugar levels partly by increasing the body's own insulin production and partly by enhancing the effect of the body's own insulin. Dialosa is used for the treatment of type 2 (adult type) diabetes when diet, weight loss and exercise alone do not produce a sufficient result. Dialosa may also be used together with insulin. 2. BEFORE YOU TAKE DIALOSA Do not use Dialosa - if you are allergic (hypersensitive) to glimepiride, other medicinal products from the same group (sulphonylureas or sulphonamides) or any of the other ingredients of Dialosa. - if you have insulin-dependent (type 1) diabetes, hyperglycaemic or hypoglycaemic coma (unconsciousness) and ketoacidosis (increased levels of acids in the body) or severely impaired kidney or liver function. Take special care with Dialosa: - Blood and urine sugar levels should be monitored regularly. The risk of an excessive reduction in blood sugar levels (hypoglycaemia) is increased during the first few weeks of Dialosa therapy. - In impaired kidney and liver function as well as longer term fasting, the blood sugar reducing effect of Dialosa may be too strong. - If you are simultaneously using other medicinal or health products (see section Using other medicines). - Lowering of the haemoglobin level and breakdown of red blood cells (haemolytic anaemia) can occur in patients missing the enzyme glucose-6-phosphate dehydrogenase. Symptoms of hypoglycaemia may occur if you - are using other medicines simultaneously, - take an overdose, - have irregular meal times, 1

- have fever, - have detrimental stress, - exert yourself physically more than usual, - are using alcohol. The symptoms of hypoglycaemia (excessively low blood sugar levels) include hunger, weakness, perspiration, nervousness, tremor, paleness, headache, even convulsions and coma. Such effects usually resolve quickly after taking sugar. Therefore, always keep sugar with you in some form, for example as fructose, fruit juice, chocolate or similar. Please note that artificial sweeteners are not helpful. If taking sugar does not help or if symptoms recur, contact your doctor. The symptoms of hyperglycemia (excessively high blood sugar levels) include thirst, urinary frequency, dry mouth and dry skin. In such cases please consult your doctor. In the event of accident, surgery or fever it may be necessary to switch to insulin treatment. Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. The effect of Dialosa may be increased or reduced when used simultaneously with certain other medicines. Such medicines include: - insulin and other oral antidiabetics - certain long-acting sulphonamides - metformin - tetracyclines - salicylates and p-amino-salicylic acid - MAO inhibitors - anabolic steroids and male sex hormones - quinolone antibiotics - chloramphenicol - coumarin anticoagulants - miconazole, fluconazole - ACE inhibitors - fluoxetine - allopurinol - oestrogens and gestagens - saluretics, thiazide diuretics - thyroid hormones, glucocorticoids - phenothiazine derivatives, chlorpromazine - laxatives (in long-term use) - phenytoin - glucagon, barbiturates and rifampicin - acetazolamide Alcohol may increase or reduce the blood sugar lowering effect of Dialosa. Always consult your doctor before taking Dialosa simultaneously with other medicines. Taking Dialosa with food and drink Dialosa should be taken as a single dose shortly before or during breakfast or the first main meal of the day and swallowed whole with water (at least ½ glass). Pregnancy and breast-feeding Dialosa should not be used during pregnancy. If you are planning a pregnancy, ask your doctor about the medication. 2

It is not known whether glimepiride is excreted in breast milk. Dialosa should not be used during breast-feeding. Driving and using machines Your concentration and reactions may be reduced due to too low or too high blood sugar levels or for example due to reduced vision caused by them. This may be dangerous in situations where such skills are important (e.g. driving or using machines). Therefore, together with your doctor consider whether you should drive or use machines. Important information about some of the ingredients of Dialosa: Dialosa tablets contain lactose as an inactive substance. If your doctor has told you that you have an intolerance to some sugars, please talk to your doctor before taking this medicine. The tablets contain some colouring agents (red iron oxide E172, yellow iron oxide E172, indigo carmine aluminium lake E132 or sunset yellow FCF aluminium lake E110) that may cause hypersensitivity reactions. 3. HOW TO USE DIALOSA Always use Dialosa exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual dose in adults is 1-4 mg per day depending on blood sugar levels. The maximum daily dose is 6 mg. It is very important not to miss meals during Dialosa therapy. Insulin may be used in addition to Dialosa therapy. In this case, your doctor will determine an insulin dose suitable for you personally. If you feel that the effect of Dialosa is too strong or too weak, please contact your doctor or pharmacist. If you use more Dialosa than you should Always contact your doctor, hospital or the National Poisons Information Centre immediately. Symptoms may appear up to 24 hours after ingestion of Dialosa tablets. Overdosage symptoms include low blood sugar, nausea, vomiting, abdominal pain, restlessness, tremor, abnormal vision, coordination disorders, sleepiness, unconsciousness (coma) and convulsions. If an overdose is suspected, sugar, fruit juice or similar should be taken immediately. However, food or drink must not be given to a comatose patient. If you forget to take Dialosa Do not take a double dose to make-up for forgotten individual doses. Take your next tablet(s) as usual and continue your therapy. If you stop using Dialosa: Elevation of blood sugar levels is possible. Do not stop your treatment before you talk to your doctor. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Dialosa can cause side effects, although not everybody gets them. Rare side effects (more than 1/10 000 but fewer than 1/1000 patients): Changes in blood count (usually reversible after discontinuation of therapy) and reduction in blood sugar levels. 3

Very rare side effects (fewer than 1/10 000 patients): Nausea, vomiting, diarrhoea, a feeling of fullness, abdominal pain, reduction in liver function (e.g. cholestasis and jaundice), hepatitis, liver impairment, severe hypersensitivity reactions (dyspnoea, reduced blood pressure, shock), allergic vasculitis, photosensitivity, reduced serum sodium content. In addition, elevation of liver enzyme levels, hypersensitivity reactions of the skin, such as itching, rash and urticaria as well as cross allergy to sulphonylureas or sulphonamides may occur. Transient visual disturbances may occur, especially at the beginning of the therapy. If you experience severe or disturbing symptoms, such as jaundice or dyspnoea, contact your doctor immediately. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE DIALOSA Keep out of the reach and sight of children. Do not store above 30 0 C. Do not use Dialosa after the expiry date which is stated on the carton. The expiry date refers to the last day of that month. Do not use Dialosa if you notice visible changes in the appearance of the medicinal product. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Dialosa contains - The active substance is glimepiride. - The other ingredients are lactose monohydrate, sodium starch glycolate type A, microcrystalline cellulose, povidone K30, magnesium stearate, 1 mg tablets: red iron oxide (E172), 2 mg tablets: yellow iron oxide (E172), indigo carmine aluminium lake (E132), 3 mg tablets: yellow iron oxide (E172), 4 mg tablets: indigo carmine aluminium lake (E132), 6 mg tablets: sunset yellow FCF aluminium lake (E110). What Dialosa looks like and contents of the pack 1 mg tablets are pink, oblong with a score line on both sides. 2 mg tablets are green, oblong with a score line on both sides. 3 mg tablets are pale yellow, oblong with a score line on both sides. 4 mg tablets are pale blue, oblong with a score line on both sides. 6 mg tablets are pale orange, oblong with a score line on both sides. Contents of container: 30 tablets (in 10-tablet blister packs). Marketing Authorisation Holder and Manufacturer Specifar S.A. 1, 28 Octovriou str. 4

123 51 Ag. Varvara Athens, Greece This leaflet was last approved on The text was revised on 24.01.2008 5